Ceramic targets for radionuclide therapy
At a glance
- Project leader : Prof. Dr. Dirk Penner
- Project team : Michal Gorbar
- Project status : completed
- Funding partner : Third party
- Project partner : Kernkraftwerk Gösgen-Däniken AG
- Contact person : Dirk Penner
Radionuclide therapy is a form of targeted cancer therapy in
which specifically effective isotopes with a coordinated half-life
and radiation characteristics are brought directly to the site of
the tumour, where they can selectively combat the tumour.
The Laboratory for Ceramic Materials develops so-called targets, which consist of ceramics of special elements suitable for radiotherapy. The entire production process chain is being optimized to such an extent that in the future a medical product with maximum reliability can be manufactured.
Gorbar, Michal; Mauchle, Stéphane; Aebi, Patric; Bitterli, Beat; Penner, Dirk,
Development of Yb2O3-based ceramics for indirect production of 177Lu used in targeted radionuclide therapies.
Ceramics in Europe 2022, Kraków, Poland, 10-14 July 2022.